Liu, G.; Yuan, Z.; Wu, Z.; Yang, Q.; Ding, T.; Yu, K.; Dong, J.
CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery. Vaccines 2025, 13, 977.
https://doi.org/10.3390/vaccines13090977
AMA Style
Liu G, Yuan Z, Wu Z, Yang Q, Ding T, Yu K, Dong J.
CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery. Vaccines. 2025; 13(9):977.
https://doi.org/10.3390/vaccines13090977
Chicago/Turabian Style
Liu, Guang, Ziqing Yuan, Ziyi Wu, Qiyv Yang, Tingbo Ding, Ker Yu, and Jibin Dong.
2025. "CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery" Vaccines 13, no. 9: 977.
https://doi.org/10.3390/vaccines13090977
APA Style
Liu, G., Yuan, Z., Wu, Z., Yang, Q., Ding, T., Yu, K., & Dong, J.
(2025). CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery. Vaccines, 13(9), 977.
https://doi.org/10.3390/vaccines13090977